Research Highlights

The MGFA, in consultation with its chapters, the MGFA Medical Scientific Advisory Board, other health advocacy groups, and leaders of federal research funding bodies, including the National Institutes of Health has established a focused research agenda.  The three specific initiatives are:

Focused MGFA Research Priorities

• Etiology- what is the basic cause of the MG?
• Detection and early diagnosis:  Would earlier diagnosis lead to improved treatment? 
• Genetics of MG.
• Enhance understanding and application of current treatments of MG.
• Thymus: how exactly does the thymus gland promote the production of acetylcholine receptor antibodies? 
• New therapeutic targets identified for MG, with the goal of improved treatment responses and fewer adverse events. 
• New strategies for treatment including development of potential vaccine therapies.
• Quality of Life:  develop better strategies to improve quality of life and develop rigorous research methods to study quality of life in MG.
• Collateral effects of MG:.

MGFA-AANF Fellowship

MGFA and AANF (American Academy of Neurology Foundation) are offering a joint three year Clinician Scientist Development fellowship. The fellowship is designed to train the next generation of clinical researchers.

High Impact Pilot Projects on Myasthenia Gravis and Related Neuromuscular Junction Disorders

The Myasthenia Gravis Foundation of America requests submission of proposals to support pilot studies that are highly focused and innovative with a clear plan that will lead to new federal, pharmaceutical, or private foundation supported investigations.  The proposal should be within the scope of the research priorities of the Myasthenia Gravis Foundation.